抗菌剂
大流行
抗生素耐药性
人类免疫缺陷病毒(HIV)
风险分析(工程)
2019年冠状病毒病(COVID-19)
重症监护医学
疟疾
医学
抗生素
病毒学
生物
免疫学
传染病(医学专业)
微生物学
疾病
病理
作者
Jack A. Doolan,George T. Williams,Kira L. F. Hilton,Rajas Chaudhari,John S. Fossey,Benjamin T. Goult,Jennifer R. Hiscock
摘要
Antimicrobial resistance is directly responsible for more deaths per year than either HIV/AIDS or malaria and is predicted to incur a cumulative societal financial burden of at least $100 trillion between 2014 and 2050. Already heralded as one of the greatest threats to human health, the onset of the coronavirus pandemic has accelerated the prevalence of antimicrobial resistant bacterial infections due to factors including increased global antibiotic/antimicrobial use. Thus an urgent need for novel therapeutics to combat what some have termed the 'silent pandemic' is evident. This review acts as a repository of research and an overview of the novel therapeutic strategies being developed to overcome antimicrobial resistance, with a focus on self-assembling systems and nanoscale materials. The fundamental mechanisms of action, as well as the key advantages and disadvantages of each system are discussed, and attention is drawn to key examples within each field. As a result, this review provides a guide to the further design and development of antimicrobial systems, and outlines the interdisciplinary techniques required to translate this fundamental research towards the clinic.
科研通智能强力驱动
Strongly Powered by AbleSci AI